Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease

Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease

Show other versions (1)

© 2017 Elsevier Ltd Inflammatory bowel disease (IBD) is a chronic, idiopathic inflammatory set of conditions that can affect the entire gastrointestinal (GI) tract and is associated with an increased risk of colorectal cancer. To date there is no curative therapy for IBD; therefore life-long medicat...

Full description

Bibliographic Details
Main Authors:	Zhang, Sufeng, Langer, Robert, Traverso, Giovanni
Format:	Article
Language:	English
Published:	Elsevier BV 2021
Online Access:	https://hdl.handle.net/1721.1/136341

Similar Items

Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease
by: Zhang, Sufeng, et al.
Published: (2022)

An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
by: Ermann, J., et al.
Published: (2017)

Nanoparticulate drug delivery systems /
by: Thassu, Deepak, et al.
Published: (2007)

Emerging transporter-targeted nanoparticulate drug delivery systems
by: Hongyan Su, et al.
Published: (2019-01-01)

Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
by: Greta Volpedo, et al.
Published: (2019-02-01)

Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders
by: Stefan R. Stefanov, et al.
Published: (2021-10-01)

Past, Present, and Future Drug Delivery Systems for Antiretrovirals
by: Kirtane, Ameya, et al.
Published: (2017)

Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
by: Peng Liu, et al.
Published: (2021-09-01)

Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic Delivery
by: Cheng, Hao, et al.
Published: (2012)

Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
by: Caifang Gao, et al.
Published: (2019-06-01)

Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy
by: Theodora Amanda Seidu, et al.
Published: (2022-05-01)

Nanoparticulate drug delivery : perspectives on the transition from laboratory to market /
by: Patravale, Vandana, et al.
Published: (2012)

Advances in Nanoparticulate Drug Delivery Approaches for Sublingual and Buccal Administration
by: Susan Hua, et al.
Published: (2019-11-01)

Nanoparticulates as drug carriers /
by: Torchilin, V. P.
Published: (2006)

Lipid-Based Nanoparticulate Systems for the Ocular Delivery of Bioactives with Anti-Inflammatory Properties
by: Raquel da Ana, et al.
Published: (2022-10-01)

Improved uptake and therapeutic intervention of curcumin via designing binary lipid nanoparticulate formulation for oral delivery in inflammatory bowel disorder
by: Manu Sharma, et al.
Published: (2019-12-01)

Microbial therapeutics: New opportunities for drug delivery
by: Jimenez, Miguel, et al.
Published: (2020)

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
by: Ryu Keinosuke, et al.
Published: (2009-11-01)

Drug Targeting of Inflammatory Bowel Diseases by Biomolecules
by: Joana Costa Antunes, et al.
Published: (2021-08-01)

Evolution of macromolecular complexity in drug delivery systems
by: Kakkar, Ashok, et al.
Published: (2021)

Medicinal plant-based drug delivery system for inflammatory bowel disease
by: Ningcen Li, et al.
Published: (2023-03-01)

Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
by: Deepak A. Subramanian, et al.
Published: (2022-08-01)

Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
by: Subramanian, Deepak A., et al.
Published: (2022)

Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis
by: Danni Yan, et al.
Published: (2023-04-01)

Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
by: Tan W, et al.
Published: (2011-08-01)

Oral delivery of biologics using drug-device combinations
by: Caffarel Salvador, Ester, et al.
Published: (2020)

Biologic targeting in the treatment of inflammatory bowel diseases
by: Matteo Bosani, et al.
Published: (2009-02-01)

Utilization of nanoparticulate therapy in cancer targeting
by: Eshwaran Narayanan, et al.
Published: (2018-01-01)

Preparation and Characterization of Nanoparticulate Drug Delivery System for Naproxen Sodium Using Various Desolvating Agents
by: Huda Syed, et al.
Published: (2019-09-01)

Tetraethyl Orthosilicate-Based Hydrogels for Drug Delivery—Effects of Their Nanoparticulate Structure on Release Properties
by: Bogdan A. Serban, et al.
Published: (2020-10-01)

Pharmaceutical Properties of Nanoparticulate Formulation Composed of TPGS and PLGA for Controlled Delivery of Anticancer Drug
by: Mu, L., et al.
Published: (2003)

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
by: Jun Zhou, et al.
Published: (2022-06-01)

The common pathways and targeted drugs for psoriasis and inflammatory bowel disease
by: Jinsheng LI, et al.
Published: (2022-08-01)

Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease
by: Sahar Mohajeri, et al.
Published: (2022-11-01)

New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
by: Adrian H. Teruel, et al.
Published: (2020-09-01)

Special Issue “Drug Treatments for Inflammatory Bowel Diseases”
by: Anderson Luiz-Ferreira, et al.
Published: (2023-12-01)

Current and emerging drugs for the treatment of inflammatory bowel disease
by: Triantafillidis JK, et al.
Published: (2011-04-01)

Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases
by: Andrea Padoan, et al.
Published: (2023-06-01)

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
by: Bosani M, et al.
Published: (2014-01-01)

Targeted Delivery of Nanoparticulate Cytochrome C into Glioma Cells Through the Proton-Coupled Folate Transporter
by: Yuriy V. Kucheryavykh, et al.
Published: (2019-04-01)